Nob Hill Therapeutics, Inc. — Form D/A
Nob Hill Therapeutics, Inc. of Albuquerque, NM, a company, filed a Form D amendment with the SEC on 2018-04-25. The offering totals $250K, of which $250K was reported sold. Industry: Other.
Offering
- Filed: 2018-04-25
- Form: D/A
- Accession: 0001690041-18-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $250K
- Amount sold: $250K
- Investors: 1
- Date of first sale: 2016-11-01
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-274492
Issuer
- Name: Nob Hill Therapeutics, Inc.
- CIK: 0001690041
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 5901 Indian School Road, Suite 209, Albuquerque, NM, 87110
- Phone: 858-356-9158
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Jee Shin | Director | Pleasanton, CA |
| Mark Kidd | Executive Officer | ROYERSFORD, PA |
| Jee Shin | Executive Officer | Pleasanton, CA |
| Robert Calvin Goforth | Director | Fayetteville, AR |
| Chris Calvin Japp | Director | Albuquerque, NM |
| Noel Calvin Greenberger | Director | Albuquerque, NM |
| Noel Calvin Greenberger | Executive Officer | Albuquerque, NM |
| Paul Calvin Atkins | Director | Fayetteville, AR |
| Yun Calvin Li | Director | Fayetteville, AR |
| Yun Calvin Li | Executive Officer | Fayetteville, AR |
| Yun Li | Director | Fayetteville, AR |
| Yun Li | Executive Officer | Fayetteville, AR |
| R. CALVIN GOFORTH | Director | FAYETTEVILLE, AR |
Other filings by this issuer (7)
More